Viprostol
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Viprostol ( , , ; developmental code name CL-115347) is a synthetic prostaglandin E2 (PGE 2 ) analogue which was under development for the treatment of alopecia (hair loss) but was never marketed. It is administered topically and was found to increase scalp hair growth in people with alopecia, albeit with mixed evidence of effectiveness. The drug was under development by American Cyanamid. It reached phase 3 clinical trials for treatment of alopecia in the 1980s, but development was discontinued due to inadequate effectiveness. Viprostol is also a vasodilator and was originally developed for the treatment of hypertension in the mid-1970s before being repurposed for alopecia.
Viprostol ( , , ; developmental code name CL-115347) is a synthetic prostaglandin E2 (PGE 2 ) analogue which was under development for the treatment of alopecia (hair loss) but was never marketed. It is administered topically and was found to increase scalp hair growth in people with alopecia, albeit with mixed evidence of effectiveness. The drug was under development by American Cyanamid. It reached phase 3 clinical trials for treatment of alopecia in the 1980s, but development was discontinued due to inadequate effectiveness. Viprostol is also a vasodilator and was originally developed for the treatment of hypertension in the mid-1970s before being repurposed for alopecia.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373247306 under CC BY-SA 4.0; modifications have been made.